Riptide Bioscience, Inc.
Biotech · Private
Designed host defense peptides (dHDPs) for treating diabetic foot ulcers by eradicating biofilm-resident bacteria
- Grants
- $502K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 25
- 9 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Designed Antimicrobial Peptides for Treatment of Infectious Acne Vulgaris | $224,169 | |
| Federal grant | Department of Health and Human Services · Phase I · Designed Host Defense Pepties for the Topical Treatment of Diabetic Foot Ulcers | $278,046 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1308 | Cavatar LLC | — | — |
| 1309 | COARE BIOTECHNOLOGY, INC. | — | — |
| 1310 | Pinnacle Medicines | — | — |
| 1311 | Riptide Bioscience, Inc. | — | — |
| 1312 | TING THERAPEUTICS LLC | — | — |
| 1313 | Kodikaz Therapeutic Solutions, Inc. | — | — |
| 1314 | THERATARGET, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods for Modulating Macrophage Activityapplication
- Methods for Modulating Macrophage Activitygranted
- Peptides Having Immunomodulatory Propertiesapplication
- Antimicrobial Peptides and Methods of Using the Samegranted
- Peptides Having Immunomodulatory Propertiesapplication
- Peptides Having Immunomodulatory Propertiesgranted
- Peptides Having Anti-Inflammatory Propertiesapplication
- Antimicrobial Peptides And Methods Of Using The Samegranted
- Peptides Having Immunomodulatory Propertiesgranted
- Antimicrobial Peptides And Methods Of Use Thereofapplication
- Peptides Having Anti-Inflammatory Propertiesapplication
- Peptides Having Anti-inflammatory Propertiesgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.